Full Year 2026 Fisher & Paykel Healthcare Corporation Ltd Earnings Call Transcript
Key Points
- Fisher & Paykel Healthcare Corp Ltd (FSPKF) reported a 14% increase in operating revenue, reaching $2.3 billion for the year.
- Net profit after tax rose by 24% to $468.5 million, demonstrating strong financial performance.
- The company achieved significant growth in hospital hardware sales, particularly in the United States, with a 27% increase in constant currency.
- Gross margin improved by 122 basis points in constant currency, reaching 63.7%, due to manufacturing efficiency and other gains.
- The company declared a fully imputed final dividend of $0.33 per share, bringing the total dividends for the year to $0.52 per share, up 22% from the previous year.
- US tariffs on products sourced from New Zealand negatively impacted gross margin by approximately 90 basis points.
- Foreign currency movements unfavorably impacted net profit after tax growth by 4 percentage points, equating to a $15 million loss.
- Operating expenses grew by 8% in constant currency, reflecting higher investments and increased personnel.
- The company faces potential ongoing impacts from the Middle East conflict, with estimated additional costs to gross margin.
- Guidance for FY27 indicates potential revenue growth of 6% to 11%, which may be seen as conservative compared to previous aspirations.
Please stand by. Welcome to the Fisher & Paykel Healthcare FY26 results announcement. My name is Justin, and I will be your operator for today's call. (Operator Instructions) Please note, this conference call is being recorded.
I would now like to turn the call over to Marcus Driller, VP Corporate.
Thank you, Justin. Good morning, everyone, and welcome to the conference call for Fisher & Paykel Healthcare's full-year results for the 2026 financial year. On the call today with me and Dan are Lewis Gradon, our Managing Director and CEO; Lyndal York, our Chief Financial Officer; Andy Niccol, our Chief Operating Officer; Justin Callahan, our VP of Sales and Marketing; and Andrew Somervell, our VP of Products and Technology.
Lewis and Lyndal will first provide an overview of the results, and then we'll move on to questions. We'll be discussing our results for the 12 months ended March 31, 2026.
Earlier today, we provided our 2026 annual
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
